Skip to main content
Top
Published in: Pediatric Nephrology 2/2012

Open Access 01-02-2012 | Review

Cachexia and protein-energy wasting in children with chronic kidney disease

Authors: Robert H. Mak, Wai W. Cheung, Jian-Ying Zhan, Qian Shen, Bethany J. Foster

Published in: Pediatric Nephrology | Issue 2/2012

Login to get access

Abstract

Children with chronic kidney disease (CKD) are at risk for “cachexia” or “protein-energy wasting” (PEW). These terms describe a pathophysiologic process resulting in the loss of muscle, with or without loss of fat, and involving maladaptive responses, including anorexia and elevated metabolic rate. PEW has been defined specifically in relation to CKD. We review the diagnostic criteria for cachexia and PEW in CKD and consider the limitations and applicability of these criteria to children with CKD. In addition, we present an overview of the manifestations and mechanisms of cachexia and PEW. A host of pathogenetic factors are considered, including systemic inflammation, endocrine perturbations, and abnormal neuropeptide signaling, as well as poor nutritional intake. Mortality risk, which is 100- to 200-fold higher in patients with end-stage renal disease than in the general population, is strongly correlated with the components of cachexia/PEW. Further research into the causes and consequences of wasting and growth retardation is needed in order to improve the survival and quality of life for children with CKD.
Literature
1.
go back to reference Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD (2003) Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 42:864–881PubMedCrossRef Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD (2003) Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 42:864–881PubMedCrossRef
2.
go back to reference Kopple JD (1997) McCollum Award Lecture, 1996: protein-energy malnutrition in maintenance dialysis patients. Am J Clin Nutr 65:1544–1557PubMed Kopple JD (1997) McCollum Award Lecture, 1996: protein-energy malnutrition in maintenance dialysis patients. Am J Clin Nutr 65:1544–1557PubMed
3.
go back to reference Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27:793–799PubMedCrossRef Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27:793–799PubMedCrossRef
4.
go back to reference Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Trevinho-Becerra A, Wanner C (2008) A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73:391–398PubMedCrossRef Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Trevinho-Becerra A, Wanner C (2008) A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73:391–398PubMedCrossRef
6.
go back to reference Mak RH, Cheung W (2007) Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling. Curr Opin Nephrol Hypertens 16:27–31PubMedCrossRef Mak RH, Cheung W (2007) Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling. Curr Opin Nephrol Hypertens 16:27–31PubMedCrossRef
7.
go back to reference Mak RH, Cheung W, Cone RD, Marks DL (2006) Mechanisms of disease: cytokine and adipokine signaling in uremic cachexia. Nat Clin Pract Nephrol 2:527–534PubMedCrossRef Mak RH, Cheung W, Cone RD, Marks DL (2006) Mechanisms of disease: cytokine and adipokine signaling in uremic cachexia. Nat Clin Pract Nephrol 2:527–534PubMedCrossRef
8.
go back to reference Mitch WE (2002) Insights into the abnormalities of chronic renal disease attributed to malnutrition. J Am Soc Nephrol 13(Suppl 1):S22–S27PubMed Mitch WE (2002) Insights into the abnormalities of chronic renal disease attributed to malnutrition. J Am Soc Nephrol 13(Suppl 1):S22–S27PubMed
9.
go back to reference Mitch WE (2002) Malnutrition: a frequent misdiagnosis for hemodialysis patients. J Clin Invest 110:437–439PubMed Mitch WE (2002) Malnutrition: a frequent misdiagnosis for hemodialysis patients. J Clin Invest 110:437–439PubMed
10.
go back to reference Mitch WE (2006) Proteolytic mechanisms, not malnutrition, cause loss of muscle mass in kidney failure. J Ren Nutr 16:208–211PubMedCrossRef Mitch WE (2006) Proteolytic mechanisms, not malnutrition, cause loss of muscle mass in kidney failure. J Ren Nutr 16:208–211PubMedCrossRef
11.
go back to reference Mak RH, Cheung W (2006) Energy homeostasis and cachexia in chronic kidney disease. Pediatr Nephrol 21:1807–1814PubMedCrossRef Mak RH, Cheung W (2006) Energy homeostasis and cachexia in chronic kidney disease. Pediatr Nephrol 21:1807–1814PubMedCrossRef
12.
go back to reference Lowrie EG, Lew NL (1990) Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458–482PubMed Lowrie EG, Lew NL (1990) Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458–482PubMed
13.
go back to reference Wong CS, Hingorani S, Gillen DL, Sherrard DJ, Watkins SL, Brandt JR, Ball A, Stehman-Breen CO (2002) Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease. Kidney Int 61:630–637PubMedCrossRef Wong CS, Hingorani S, Gillen DL, Sherrard DJ, Watkins SL, Brandt JR, Ball A, Stehman-Breen CO (2002) Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease. Kidney Int 61:630–637PubMedCrossRef
14.
go back to reference Bergstrom J, Lindholm B (1998) Malnutrition, cardiac disease, and mortality: an integrated point of view. Am J Kidney Dis 32:834–841PubMedCrossRef Bergstrom J, Lindholm B (1998) Malnutrition, cardiac disease, and mortality: an integrated point of view. Am J Kidney Dis 32:834–841PubMedCrossRef
15.
go back to reference Foster BJ, Leonard MB (2004) Measuring nutritional status in children with chronic kidney disease. Am J Clin Nutr 80:801–814PubMed Foster BJ, Leonard MB (2004) Measuring nutritional status in children with chronic kidney disease. Am J Clin Nutr 80:801–814PubMed
16.
go back to reference Graf L, Candelaria S, Doyle M, Kaskel F (2007) Nutrition assessment and hormonal influences on body composition in children with chronic kidney disease. Adv Chronic Kidney Dis 14:215–223PubMedCrossRef Graf L, Candelaria S, Doyle M, Kaskel F (2007) Nutrition assessment and hormonal influences on body composition in children with chronic kidney disease. Adv Chronic Kidney Dis 14:215–223PubMedCrossRef
17.
go back to reference Jones CH, Wells L, Stoves J, Farquhar F, Woodrow G (2002) Can a reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients? Am J Kidney Dis 39:872–875PubMedCrossRef Jones CH, Wells L, Stoves J, Farquhar F, Woodrow G (2002) Can a reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients? Am J Kidney Dis 39:872–875PubMedCrossRef
18.
go back to reference Kalantar-Zadeh K, Kopple JD (2001) Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 38:1343–1350PubMedCrossRef Kalantar-Zadeh K, Kopple JD (2001) Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 38:1343–1350PubMedCrossRef
19.
go back to reference Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH (2001) A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients.[comment]. Am J Kidney Dis 38:1251–1263PubMedCrossRef Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH (2001) A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients.[comment]. Am J Kidney Dis 38:1251–1263PubMedCrossRef
20.
go back to reference Kaysen GA (2000) Malnutrition and the acute-phase reaction in dialysis patients-how to measure and how to distinguish. Nephrol Dial Transplant 15:1521–1524PubMedCrossRef Kaysen GA (2000) Malnutrition and the acute-phase reaction in dialysis patients-how to measure and how to distinguish. Nephrol Dial Transplant 15:1521–1524PubMedCrossRef
21.
go back to reference Yeun JY, Levine RA, Mantadilok V, Kaysen GA (2000) C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35:469–476PubMedCrossRef Yeun JY, Levine RA, Mantadilok V, Kaysen GA (2000) C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35:469–476PubMedCrossRef
22.
go back to reference Kalantar-Zadeh K, Kleiner M, Dunne E, Ahern K, Nelson M, Koslowe R (1998) Luft FC (1998) Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. Am J Kidney Dis 31:263–272PubMedCrossRef Kalantar-Zadeh K, Kleiner M, Dunne E, Ahern K, Nelson M, Koslowe R (1998) Luft FC (1998) Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. Am J Kidney Dis 31:263–272PubMedCrossRef
23.
go back to reference Steiber AL, Kalantar-Zadeh K, Secker D, McCarthy M, Sehgal A, McCann L (2004) Subjective global assessment in chronic kidney disease: a review. J Ren Nutr 14:191–200PubMed Steiber AL, Kalantar-Zadeh K, Secker D, McCarthy M, Sehgal A, McCann L (2004) Subjective global assessment in chronic kidney disease: a review. J Ren Nutr 14:191–200PubMed
24.
go back to reference Friedman AN, Fadem SZ (2010) Reassessment of albumin as a nutritional marker in kidney disease. J Am Soc Nephrol 21:223–230PubMedCrossRef Friedman AN, Fadem SZ (2010) Reassessment of albumin as a nutritional marker in kidney disease. J Am Soc Nephrol 21:223–230PubMedCrossRef
25.
go back to reference Rambod M, Bross R, Zitterkoph J, Benner D, Pithia J, Colman S, Kovesdy CP, Kopple JD, Kalantar-Zadeh K (2009) Association of malnutrition-inflammation score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis 53:298–309PubMedCrossRef Rambod M, Bross R, Zitterkoph J, Benner D, Pithia J, Colman S, Kovesdy CP, Kopple JD, Kalantar-Zadeh K (2009) Association of malnutrition-inflammation score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis 53:298–309PubMedCrossRef
26.
go back to reference Noori N, Kovesdy CP, Dukkipati R, Kim Y, Duong U, Bross R, Oreopoulos A, Luna A, Benner D, Kopple KD, Kalantar-Zadeh K (2010) Survival predictability of fat mass in men and women undergoin maintenance hemodialysis. Am J Clin Nutr 92:1060–1070PubMedCrossRef Noori N, Kovesdy CP, Dukkipati R, Kim Y, Duong U, Bross R, Oreopoulos A, Luna A, Benner D, Kopple KD, Kalantar-Zadeh K (2010) Survival predictability of fat mass in men and women undergoin maintenance hemodialysis. Am J Clin Nutr 92:1060–1070PubMedCrossRef
27.
go back to reference Benuck I, Gidding SS, Donovan M (1995) Year-to-year variability of cholesterol levels in a pediatric practice. Arch Pediatr Adolesc Med 149(3):292–296PubMedCrossRef Benuck I, Gidding SS, Donovan M (1995) Year-to-year variability of cholesterol levels in a pediatric practice. Arch Pediatr Adolesc Med 149(3):292–296PubMedCrossRef
28.
go back to reference Stenvinkel P (2001) Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif 19:53–61PubMedCrossRef Stenvinkel P (2001) Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif 19:53–61PubMedCrossRef
29.
go back to reference Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL (1998) Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia and mortality in hemodialysis patients. Am J Kidney Dis 32:107–114PubMedCrossRef Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL (1998) Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia and mortality in hemodialysis patients. Am J Kidney Dis 32:107–114PubMedCrossRef
30.
go back to reference Freeman DS, Ogden CL, Berenson GS, Horlick M (2005) Body mass index and body fatness in childhood. Curr Opin Clin Nutr Metab Care 8:618–623CrossRef Freeman DS, Ogden CL, Berenson GS, Horlick M (2005) Body mass index and body fatness in childhood. Curr Opin Clin Nutr Metab Care 8:618–623CrossRef
31.
go back to reference Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB (2005) Survival advantages of obesity in dialysis patients. Am J Clin Nutr 81:543–554PubMed Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB (2005) Survival advantages of obesity in dialysis patients. Am J Clin Nutr 81:543–554PubMed
32.
go back to reference Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ (1998) Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Clin Nutr 31:997–1006 Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ (1998) Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Clin Nutr 31:997–1006
33.
go back to reference Wong CS, Gipson DS, Gillen DL, Emerson S, Koepsell T, Sherrard DJ, Watkins SL, Stehman-Breen C (2000) Anthropometric measures and risk of death in children with end-stage renal disease. Am J Kidney Dis 36:811–819PubMedCrossRef Wong CS, Gipson DS, Gillen DL, Emerson S, Koepsell T, Sherrard DJ, Watkins SL, Stehman-Breen C (2000) Anthropometric measures and risk of death in children with end-stage renal disease. Am J Kidney Dis 36:811–819PubMedCrossRef
34.
go back to reference Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL (2002) 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 246:1–19 Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL (2002) 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 246:1–19
36.
go back to reference No authors listed (2000) Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI. National Kidney Foundation. Am J Kidney Dis 35(6 Suppl 2):S1–S140 No authors listed (2000) Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI. National Kidney Foundation. Am J Kidney Dis 35(6 Suppl 2):S1–S140
37.
go back to reference World Health Organization Expert Committee on Physical Status (1996). The Use and Interpretation of Anthropometry. Physical Status: Report of a WHO Expert Committee: WHO Technical Report Series 854, WHO, Geneva World Health Organization Expert Committee on Physical Status (1996). The Use and Interpretation of Anthropometry. Physical Status: Report of a WHO Expert Committee: WHO Technical Report Series 854, WHO, Geneva
38.
go back to reference World Health Organization (1995) Physical status: the use and interpretation of anthropometry. WHO Technical Report Series. World Health Organization, Geneva World Health Organization (1995) Physical status: the use and interpretation of anthropometry. WHO Technical Report Series. World Health Organization, Geneva
39.
go back to reference Furth SL, Stablein D, Fine RN, Powe NR, Fivush BA (2002) Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 109:909–913PubMedCrossRef Furth SL, Stablein D, Fine RN, Powe NR, Fivush BA (2002) Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 109:909–913PubMedCrossRef
40.
go back to reference Kalantar-Zadeh K (2005) Causes and consequences of the reverse epidemiology of body mass index in dialysis patients. J Ren Nutr 15:142–147PubMedCrossRef Kalantar-Zadeh K (2005) Causes and consequences of the reverse epidemiology of body mass index in dialysis patients. J Ren Nutr 15:142–147PubMedCrossRef
41.
go back to reference Foster BJ, Kalkwarf HJ, Shults J, Zemel BS, Wetzsteon RJ, Thayu M, Foerster DL, Leonard MB (2010) Chronic kidney disease is associated with muscle deficits in children. J Am Soc Nephrol. doi:10.1681/ASN.2010060603 PubMed Foster BJ, Kalkwarf HJ, Shults J, Zemel BS, Wetzsteon RJ, Thayu M, Foerster DL, Leonard MB (2010) Chronic kidney disease is associated with muscle deficits in children. J Am Soc Nephrol. doi:10.​1681/​ASN.​2010060603 PubMed
42.
go back to reference Bross R, Chandramohan G, Kovesdy CP, Orepoulos A, Noori N, Golden S, Benner D, Kopple JD, Kalantar-Zadeh K (2010) Comparing body composition assessment tests in long-term hemodialysis patients. Am J Kidney Dis 55:885–896PubMedCrossRef Bross R, Chandramohan G, Kovesdy CP, Orepoulos A, Noori N, Golden S, Benner D, Kopple JD, Kalantar-Zadeh K (2010) Comparing body composition assessment tests in long-term hemodialysis patients. Am J Kidney Dis 55:885–896PubMedCrossRef
43.
go back to reference Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD (2004) Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 80:299–307PubMed Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD (2004) Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 80:299–307PubMed
44.
go back to reference Betts P, Magrath G (1974) Growth pattern and dietary intake of children with chronic renal insufficiency. Br Med J 2:189–193PubMedCrossRef Betts P, Magrath G (1974) Growth pattern and dietary intake of children with chronic renal insufficiency. Br Med J 2:189–193PubMedCrossRef
45.
go back to reference Abitbol CL, Zilleruelo G, Montane B, Strauss J (1993) Growth of uremic infants on forced feeding regimens. Pediatr Nephrol 7:173–177PubMedCrossRef Abitbol CL, Zilleruelo G, Montane B, Strauss J (1993) Growth of uremic infants on forced feeding regimens. Pediatr Nephrol 7:173–177PubMedCrossRef
46.
go back to reference Ledermann SE, Shaw V, Trompeter RS (1999) Long-term enteral nutrition in infants and young children with chronic renal failure. Pediatr Nephrol 13:870–875PubMedCrossRef Ledermann SE, Shaw V, Trompeter RS (1999) Long-term enteral nutrition in infants and young children with chronic renal failure. Pediatr Nephrol 13:870–875PubMedCrossRef
47.
go back to reference Pollock C, Voss D, Hodson E, Crompton C (2005) The CARI guidelines. Nutrition and growth in kidney disease. Nephrology 10(Suppl 5):S177–S230PubMed Pollock C, Voss D, Hodson E, Crompton C (2005) The CARI guidelines. Nutrition and growth in kidney disease. Nephrology 10(Suppl 5):S177–S230PubMed
48.
go back to reference Mekhali D, Shaw V, Ledermann WE, Rees L (2010) Long term outcome of infants with severe chronic kidney disease. Clin J Am Soc Nephrol 5:10–17CrossRef Mekhali D, Shaw V, Ledermann WE, Rees L (2010) Long term outcome of infants with severe chronic kidney disease. Clin J Am Soc Nephrol 5:10–17CrossRef
49.
go back to reference Sienna JL, Saqan R, The JC, Frieling ML, Secker D, Cornelius V, Geary DF (2010) Body size in children with chronic kidney disease after gastrostomy tube feeding. Pediatr Nephrol 25:2115–2121PubMedCrossRef Sienna JL, Saqan R, The JC, Frieling ML, Secker D, Cornelius V, Geary DF (2010) Body size in children with chronic kidney disease after gastrostomy tube feeding. Pediatr Nephrol 25:2115–2121PubMedCrossRef
50.
go back to reference Bellisle F, Dartois AM, Kleinknecht C, Broyer M (1995) Alteration of the taste for sugar in renal insufficiency: study in the child. Néphrologie 16:203–208PubMed Bellisle F, Dartois AM, Kleinknecht C, Broyer M (1995) Alteration of the taste for sugar in renal insufficiency: study in the child. Néphrologie 16:203–208PubMed
51.
go back to reference Cheung WW, Paik KH, Mak RH (2010) Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol 25:711–724PubMedCrossRef Cheung WW, Paik KH, Mak RH (2010) Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol 25:711–724PubMedCrossRef
52.
go back to reference Mak RH, Cheung W, Cone RD, Marks DL (2006) Leptin and inflammation-associated cachexia in chronic kidney disease. Kidney Int 69:794–797PubMedCrossRef Mak RH, Cheung W, Cone RD, Marks DL (2006) Leptin and inflammation-associated cachexia in chronic kidney disease. Kidney Int 69:794–797PubMedCrossRef
53.
go back to reference Mak RH, Cheung W, Purnell J (2007) Ghrelin in chronic kidney disease: too much or too little? Perit Dial Int 27:51–55PubMed Mak RH, Cheung W, Purnell J (2007) Ghrelin in chronic kidney disease: too much or too little? Perit Dial Int 27:51–55PubMed
54.
go back to reference Daschner M, Tonshoff B, Blum WF, Englaro P, Wingen AM, Schaefer F, Wuhl E, Rascher W, Mehls O (1998) Inappropriate elevation of serum leptin levels in children with chronic renal failure. European study group for nutritional treatment of chronic renal failure in children. J Am Soc Nephrol 9:1074–1079PubMed Daschner M, Tonshoff B, Blum WF, Englaro P, Wingen AM, Schaefer F, Wuhl E, Rascher W, Mehls O (1998) Inappropriate elevation of serum leptin levels in children with chronic renal failure. European study group for nutritional treatment of chronic renal failure in children. J Am Soc Nephrol 9:1074–1079PubMed
55.
go back to reference Cheung WW, Yu PX, Little BM, Cone RD, Marks DL, Mak RH (2005) Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest 115:1659–1665PubMedCrossRef Cheung WW, Yu PX, Little BM, Cone RD, Marks DL, Mak RH (2005) Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest 115:1659–1665PubMedCrossRef
56.
go back to reference Mak RH, Cheung W (2007) Therapeutic strategy for cachexia in chronic kidney disease. Curr Opin Nephrol Hypertens 16:542–546PubMedCrossRef Mak RH, Cheung W (2007) Therapeutic strategy for cachexia in chronic kidney disease. Curr Opin Nephrol Hypertens 16:542–546PubMedCrossRef
57.
go back to reference Rodriguez-Carmona A, Perez Fontan M, Cordido F, Garcia Falcon T, Garcia-Buela J (2000) Hyperleptinemia is not correlated with markers of protein malnutrition in chronic renal failure. A cross-sectional study in predialysis, peritoneal dialysis and hemodialysis patients. Nephron 86:274–280PubMedCrossRef Rodriguez-Carmona A, Perez Fontan M, Cordido F, Garcia Falcon T, Garcia-Buela J (2000) Hyperleptinemia is not correlated with markers of protein malnutrition in chronic renal failure. A cross-sectional study in predialysis, peritoneal dialysis and hemodialysis patients. Nephron 86:274–280PubMedCrossRef
58.
go back to reference Bossola M, Muscaritoli M, Valenza V, Panocchia N, Tazza L, Cascino A, Laviano A, Liberatori M, Lodovica Mousser M, Rossi Fanelli F, Luciani F (2004) Anorexia and serum leptin levels in hemodialysis patients. Nephron Clin Pract 97:c76–c82PubMedCrossRef Bossola M, Muscaritoli M, Valenza V, Panocchia N, Tazza L, Cascino A, Laviano A, Liberatori M, Lodovica Mousser M, Rossi Fanelli F, Luciani F (2004) Anorexia and serum leptin levels in hemodialysis patients. Nephron Clin Pract 97:c76–c82PubMedCrossRef
59.
go back to reference Stenvinkel P, Lindholm B, Lonnqvist F, Katzarski K, Heimburger O (2000) Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 11:1303–1309PubMed Stenvinkel P, Lindholm B, Lonnqvist F, Katzarski K, Heimburger O (2000) Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 11:1303–1309PubMed
61.
go back to reference Perez-Fontan M, Cordido F, Rodriguez-Carmona A, Peteiro J, Garcia-Naveiro R, Garcia-Buela J (2004) Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis. Nephrol Dial Transplant 19:2095–2100PubMedCrossRef Perez-Fontan M, Cordido F, Rodriguez-Carmona A, Peteiro J, Garcia-Naveiro R, Garcia-Buela J (2004) Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis. Nephrol Dial Transplant 19:2095–2100PubMedCrossRef
62.
go back to reference Szczepanska M, Szprynger K, Mazur B, Zwolinska D, Killis-Pstrusinska K, Makulska I (2007) Plasma ghrelin levels in children with chronic renal failure on peritoneal dialysis. Perit Dial Int 27:61–66PubMed Szczepanska M, Szprynger K, Mazur B, Zwolinska D, Killis-Pstrusinska K, Makulska I (2007) Plasma ghrelin levels in children with chronic renal failure on peritoneal dialysis. Perit Dial Int 27:61–66PubMed
63.
go back to reference Iglesias P, Diez JJ, Fernandez-Reyes MJ, Codoceo R, Alvarez-Fidalgo P, Bajo MA, Aguilera A, Selgas R (2006) Serum ghrelin concentration in patients with chronic renal failure undergoing dialysis. Clin Endocrinol 64:68–73CrossRef Iglesias P, Diez JJ, Fernandez-Reyes MJ, Codoceo R, Alvarez-Fidalgo P, Bajo MA, Aguilera A, Selgas R (2006) Serum ghrelin concentration in patients with chronic renal failure undergoing dialysis. Clin Endocrinol 64:68–73CrossRef
64.
go back to reference Hosoda H, Kojima M, Matsuo H, Kangewa K (2000) Purification and characterization of rat des-Gln14-ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J Biol Chem 275:21995–22000PubMedCrossRef Hosoda H, Kojima M, Matsuo H, Kangewa K (2000) Purification and characterization of rat des-Gln14-ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J Biol Chem 275:21995–22000PubMedCrossRef
65.
go back to reference Hosoda H, Kojima M, Matsuo H, Kangewa K (2000) Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 279:909–913PubMedCrossRef Hosoda H, Kojima M, Matsuo H, Kangewa K (2000) Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 279:909–913PubMedCrossRef
66.
go back to reference Yoshimoto A, Mori K, Sugawara A, Mukovama M, Yahata K, Suganami T, Takaya K, Hosodo H, Kojima M, Kangawa K, Nakao K (2002) Plasma ghrelin and desacyl ghrelin concentration in renal failure. J Am Soc Nephrol 13:2748–2752PubMedCrossRef Yoshimoto A, Mori K, Sugawara A, Mukovama M, Yahata K, Suganami T, Takaya K, Hosodo H, Kojima M, Kangawa K, Nakao K (2002) Plasma ghrelin and desacyl ghrelin concentration in renal failure. J Am Soc Nephrol 13:2748–2752PubMedCrossRef
67.
go back to reference Perez-Fontan M, Cordido F, Rodriguez-Carmona A, Garcia-Naveiro R, Isidro ML, Villaverde P, Garcia-Buela J (2005) Acute plasma ghrelin and leptin responses to oral feeding or intraperitoneal hypertonic glucose-based dialysate in patients with chronic renal failure. Kidney Int 68:2877–2885PubMedCrossRef Perez-Fontan M, Cordido F, Rodriguez-Carmona A, Garcia-Naveiro R, Isidro ML, Villaverde P, Garcia-Buela J (2005) Acute plasma ghrelin and leptin responses to oral feeding or intraperitoneal hypertonic glucose-based dialysate in patients with chronic renal failure. Kidney Int 68:2877–2885PubMedCrossRef
68.
go back to reference Akamizu T, Shinomiya T, Irako T, Fukunaga M, Nakai Y, Kangawa K (2005) Separate measurement of plasma levels in acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay. J Clin Endocrinol Metab 90:6–9PubMedCrossRef Akamizu T, Shinomiya T, Irako T, Fukunaga M, Nakai Y, Kangawa K (2005) Separate measurement of plasma levels in acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay. J Clin Endocrinol Metab 90:6–9PubMedCrossRef
69.
go back to reference Ayala ER, Pecoits-Filho R, Heimburger O, Lindholm B, Nordfors L, Stenvinkel P (2004) Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant 19:421–426CrossRef Ayala ER, Pecoits-Filho R, Heimburger O, Lindholm B, Nordfors L, Stenvinkel P (2004) Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant 19:421–426CrossRef
70.
go back to reference Wang AY, Sea MM, Tang N, Sanderson JE, Lui SF, Li PK, Woo J (2004) Resting energy expenditure and subsequent mortality risk in peritoneal dialysis patients. J Am Soc Nephrol 15:3134–3143PubMedCrossRef Wang AY, Sea MM, Tang N, Sanderson JE, Lui SF, Li PK, Woo J (2004) Resting energy expenditure and subsequent mortality risk in peritoneal dialysis patients. J Am Soc Nephrol 15:3134–3143PubMedCrossRef
71.
go back to reference Argiles JM, Busquets S, Lopez-Sorian FJ (2002) The role of uncoupling proteins in pathophysiological states. Biochem Biophys Res Commun 293:1145–1152PubMedCrossRef Argiles JM, Busquets S, Lopez-Sorian FJ (2002) The role of uncoupling proteins in pathophysiological states. Biochem Biophys Res Commun 293:1145–1152PubMedCrossRef
72.
go back to reference Hansen ES, Knudsen J (1986) Parallel measurements of heat production and thermogenin content in brown fat cells during cold acclimation of rats. Biosci Rep 6:31–38PubMedCrossRef Hansen ES, Knudsen J (1986) Parallel measurements of heat production and thermogenin content in brown fat cells during cold acclimation of rats. Biosci Rep 6:31–38PubMedCrossRef
73.
go back to reference Rothwell NJ, Stock MJ (1979) A role for brown adipose tissue in diet-induced thermogenesis. Nature 281:31–35PubMedCrossRef Rothwell NJ, Stock MJ (1979) A role for brown adipose tissue in diet-induced thermogenesis. Nature 281:31–35PubMedCrossRef
74.
go back to reference Cheung WW, Huo HJ, Markison S, Chen C, Foster AC, Marks DL, Mak RH (2007) Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice. J Am Soc Nephrol 18:2517–2524PubMedCrossRef Cheung WW, Huo HJ, Markison S, Chen C, Foster AC, Marks DL, Mak RH (2007) Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice. J Am Soc Nephrol 18:2517–2524PubMedCrossRef
75.
go back to reference Zhang L, Du J, Hu Z, Han G, Delafontaine P, Garcia G, Mitch WE (2009) IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. J Am Soc Nephrol 20:604–612PubMedCrossRef Zhang L, Du J, Hu Z, Han G, Delafontaine P, Garcia G, Mitch WE (2009) IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. J Am Soc Nephrol 20:604–612PubMedCrossRef
76.
go back to reference Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr (2000) NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289:2363–2366PubMedCrossRef Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr (2000) NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289:2363–2366PubMedCrossRef
77.
go back to reference Lee SW, Dai G, Hu Z, Wang X, Du J, Mitch WE (2004) Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteosome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol 15:1537–1545PubMedCrossRef Lee SW, Dai G, Hu Z, Wang X, Du J, Mitch WE (2004) Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteosome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol 15:1537–1545PubMedCrossRef
78.
go back to reference Cheung WW, Rosengren S, Boyle DL, Mak RH (2008) Modulation of melanocortin signaling ameliorates uremic cachexia. Kidney Int 74:180–186PubMedCrossRef Cheung WW, Rosengren S, Boyle DL, Mak RH (2008) Modulation of melanocortin signaling ameliorates uremic cachexia. Kidney Int 74:180–186PubMedCrossRef
79.
go back to reference Lin SY, Chen WY, Lee FY, Huang CJ, Sheu WHH (2005) Activation of ubiquitin-proteosome pathway in a rat model with biliary cirrhosis, potential role of TNF-α. Am J Physiol Endocrinol Metab 288:E493–E501PubMedCrossRef Lin SY, Chen WY, Lee FY, Huang CJ, Sheu WHH (2005) Activation of ubiquitin-proteosome pathway in a rat model with biliary cirrhosis, potential role of TNF-α. Am J Physiol Endocrinol Metab 288:E493–E501PubMedCrossRef
80.
go back to reference Mak RH, Rotwein PS (2006) Myostatin and insulin-like growth factors in uremic sarcopenia: the yin and yang in muscle mass regulation. Kidney Int 70:410–412PubMedCrossRef Mak RH, Rotwein PS (2006) Myostatin and insulin-like growth factors in uremic sarcopenia: the yin and yang in muscle mass regulation. Kidney Int 70:410–412PubMedCrossRef
81.
go back to reference McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 387:83–90PubMedCrossRef McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 387:83–90PubMedCrossRef
82.
go back to reference Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, McPherron AC, Wolfman NM, Lee SJ (2002) Induction of cachexia in mice by systemically administered myostatin. Science 296:1486–1488PubMedCrossRef Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, McPherron AC, Wolfman NM, Lee SJ (2002) Induction of cachexia in mice by systemically administered myostatin. Science 296:1486–1488PubMedCrossRef
83.
go back to reference Kuninger DT, Rotwein PS (2003) IGF action and skeletal muscle. In: LeRoith D, Zumkeller W, Baxter R (eds) Insulin-like growth factors. Landes Bioscience/Kluwer Academic/Plenum, New York, pp 235–243 Kuninger DT, Rotwein PS (2003) IGF action and skeletal muscle. In: LeRoith D, Zumkeller W, Baxter R (eds) Insulin-like growth factors. Landes Bioscience/Kluwer Academic/Plenum, New York, pp 235–243
84.
go back to reference Mak RH, Cheung WW, Roberts CT Jr (2008) The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth Horm IGF Res 18:17–25PubMedCrossRef Mak RH, Cheung WW, Roberts CT Jr (2008) The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth Horm IGF Res 18:17–25PubMedCrossRef
85.
go back to reference Cheung WW, Mak RH (2009) Ghrelin and its analogues as therapeutic agents for anorexia and cachexia in end-stage renal disease. Kidney Int 76:135–137PubMedCrossRef Cheung WW, Mak RH (2009) Ghrelin and its analogues as therapeutic agents for anorexia and cachexia in end-stage renal disease. Kidney Int 76:135–137PubMedCrossRef
Metadata
Title
Cachexia and protein-energy wasting in children with chronic kidney disease
Authors
Robert H. Mak
Wai W. Cheung
Jian-Ying Zhan
Qian Shen
Bethany J. Foster
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 2/2012
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-011-1765-5

Other articles of this Issue 2/2012

Pediatric Nephrology 2/2012 Go to the issue